000 | 01619 a2200457 4500 | ||
---|---|---|---|
005 | 20250518003320.0 | ||
264 | 0 | _c20200305 | |
008 | 202003s 0 0 eng d | ||
022 | _a1948-7193 | ||
024 | 7 |
_a10.1021/acschemneuro.8b00496 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPopiolek, Michael | |
245 | 0 | 0 |
_aIn Vivo Modulation of Hippocampal Excitability by M4 Muscarinic Acetylcholine Receptor Activator: Implications for Treatment of Alzheimer's Disease and Schizophrenic Patients. _h[electronic resource] |
260 |
_bACS chemical neuroscience _c03 2019 |
||
300 |
_a1091-1098 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aHippocampus _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMaze Learning _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMuscarinic Agonists _xchemistry |
650 | 0 | 4 | _aOrgan Culture Techniques |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Long-Evans |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptor, Muscarinic M4 _xagonists |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
700 | 1 | _aMandelblat-Cerf, Yael | |
700 | 1 | _aYoung, Damon | |
700 | 1 | _aGarst-Orozco, Jonathan | |
700 | 1 | _aLotarski, Susan M | |
700 | 1 | _aStark, Eda | |
700 | 1 | _aKramer, Melissa | |
700 | 1 | _aButler, Christopher R | |
700 | 1 | _aKozak, Rouba | |
773 | 0 |
_tACS chemical neuroscience _gvol. 10 _gno. 3 _gp. 1091-1098 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/acschemneuro.8b00496 _zAvailable from publisher's website |
999 |
_c28953018 _d28953018 |